MANKIND PHARMA LIMITED (MANKIND)

NSE: ₹2,353.00
BSE: ₹2,354.40
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 2,300.21 2,453.35 2,358.57 2,152.69 2,403.26 2,529.74 2,396.57 2,126.59 2,541.36 2,608.78 2,632.68 2,581.82
YOY Revenue Growth % - - - - 4.48% 3.11% 1.61% -1.21% 5.75% 3.12% 9.85% 21.41%
Other Income 57.44 58.12 67.23 83.85 94.83 105.76 69.82 219.32 64.22 77.67 56.52 126.70
Total Income 2,357.65 2,511.46 2,425.80 2,236.54 2,498.09 2,635.50 2,466.39 2,345.91 2,605.58 2,686.45 2,689.20 2,708.52
Total Expenses + 1,831.25 1,899.50 1,849.45 1,691.68 1,920.72 1,865.05 1,942.14 1,917.16 2,111.92 2,161.82 2,100.49 1,897.69
Cost of Materials Consumed 213.41 229.96 205.21 213.15 204.24 182.12 179.72 216.76 224.76 230.46 201.14 203.58
Employee Benefit Expense 481.20 500.29 492.68 507.93 522.10 525.86 521.79 536.75 584.87 600.29 617.33 550.85
Other Expenses 490.24 551.52 533.07 474.47 622.47 548.48 474.45 555.44 613.78 604.54 575.16 538.87
Operating Profit 468.96 553.84 509.12 461.01 482.54 664.69 454.43 209.43 429.44 446.96 532.19 684.13
OPM % 20.4% 22.6% 21.6% 21.4% 20.1% 26.3% 19% 9.8% 16.9% 17.1% 20.2% 26.5%
Profit Before Tax + 526.39 611.96 576.35 544.86 577.37 770.45 524.25 428.75 493.66 524.63 505.29 788.01
Tax Expense 117.11 139.08 89.28 90.69 63.88 136.02 107.87 46.29 80.90 65.73 55.82 74.40
Tax % 22.2% 22.7% 15.5% 16.6% 11.1% 17.7% 20.6% 10.8% 16.4% 12.5% 11% 9.4%
Profit After Tax 409.28 472.88 487.07 454.17 513.49 634.43 416.38 382.46 412.76 458.90 449.47 713.61
EPS (Basic) 10.22 11.80 12.16 11.34 12.82 15.84 10.35 18.54 10.00 11.12 10.89 17.29

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024
Revenue from Operations 10,421.18 9,497.80 9,264.81
YOY Revenue Growth % 9.72% 2.51% -
Other Income 326.10 493.21 266.64
Total Income 10,747.28 9,991.01 9,531.45
Total Expenses + 8,326.04 7,685.02 7,271.88
Cost of Materials Consumed 860.52 800.43 861.74
Employee Benefit Expense 2,367.04 2,131.67 1,982.10
Other Expenses 2,343.05 2,206.69 2,049.30
Operating Profit 2,095.14 1,812.78 1,992.93
OPM % 20.1% 19.1% 21.5%
Profit Before Exceptional 2,421.24 2,305.99 2,259.57
Exceptional Items -106.24 0.00 0.00
Profit Before Tax + 2,315.00 2,305.99 2,259.57
Tax Expense 277.44 360.51 436.16
Tax % 12% 15.6% 19.3%
Profit After Tax 2,037.56 1,945.48 1,823.41
EPS (Basic) 49.37 94.80 45.52

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 20,334.63 19,031.51 5,858.79
Property, Plant & Equipment 1,938.85 1,941.45 1,811.33
Capital Work in Progress 387.27 191.36 112.88
Non-Current Investments 15,472.01 15,124.52 2,190.62
Goodwill 95.31 9.96 6.56
Other Intangible Assets 1,891.65 1,519.34 1,581.19
Current Assets + 4,287.98 4,794.11 5,556.22
Inventories 1,087.84 1,090.98 1,075.59
Trade Receivables 1,163.63 894.67 749.47
Cash and Cash Equivalents 87.66 200.29 189.20
Current Investments 1,000.00 1,000.00 1,000.00
LIABILITIES & EQUITY
Total Equity 16,396.94 14,640.27 9,623.81
Equity Share Capital 41.28 41.26 40.06
Other Equity 16,355.66 14,599.01 9,583.75
Non-Current Liabilities 2,755.18 5,096.53 200.54
Current Liabilities 5,473.19 4,091.52 1,593.36
Total Liabilities 8,228.37 9,188.05 1,793.90

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024
Cash from Operating Activities 2,751.99 2,322.16 1,982.97
Cash from Investing Activities -387.96 -12,114.68 -1,919.12
Cash from Financing Activities -2,476.92 9,783.47 -8.68
Net Increase/Decrease in Cash -113.02 -11.33 55.07